Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300705.SZ

BUYREMOVE

Hunan Jiudian Pharmaceutical Co., Ltd. · Healthcare · China · $869M · Avg Vol: $8M/d

70
StockRank
Q
71
V
58
M
28
P/E (TTM)
12.9x
ROE
14.5%
D/E
0.2x
Dividend %
3.8%
AI CONVICTION THESIS

Hunan Jiudian is a high-quality pharmaceutical company specializing in transdermal patches, but it does not operate as a global CDMO and lacks direct alignment with our macro themes.

COMPANY DESCRIPTION

Hunan Jiudian Pharmaceutical Co., Ltd. develops and manufactures pharmaceutical formulations, active ingredients (APIs), and excipients, with a market-leading specialization in transdermal drug delivery systems like gel patches. The company's competitive moat is its vertically integrated "API + formulation" business model and proprietary formulation technologies that yield high-barrier topical preparations. It is a fast-growing specialty pharmaceutical leader in China's pain management and transdermal patch markets.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue344M398M433M460M10.2%
EPS0.090.110.160.1417.9%
Shares480M483M496M500M+4.2%
Debt47M58M45M78M18.6%
Equity229M292M373M393M19.6%
Op CF40M64M110M96M34.0%
Inv CF-64M-63M-96M-94M
Fin CF18M11M-11M722,752
Loading...
PRICE (1M)-20.2%
1.511.621.731.831.94May 6May 27Jun 16
SMA 50SMA 200
Close
$1.51
RSI (14)
23.3
52W High
$2.95
From 52W High
0.5%

SCORE BREAKDOWN

Quality
71
ROIC
15.1%85.1
ROE
14.5%81.8
GP/Assets
53.7%88.4
Op. Margin
11.7%69.6
FCF/Assets
-6.0%34.3
Piotroski
83.5
Int. Cover
36.1x80.3
D/E Ratio
0.24x47.9
Current Ratio
3.73x61.2
Value
58
P/E (TTM)
12.9x80.1
EV/EBITDA
9.2x44.6
P/FCF
N/A
P/B
1.9x57.0
P/S
1.7x71.7
Div Yield
3.8%81.7
Momentum
28
52W High %
51%25.2
RS 6M
-42%27.6
SMA 50/200
0.83x17.3
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+74%64.3
Q Growth
-55%8.7

FUNDAMENTALS

Market Cap
$869M
P/E (Forward)
7.4x
Gross Margin
71.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300705.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300705.SZHunan Jiudian Pharmaceutical Co., Ltd.(you)$869M70BUY
603439.SSGuizhou Sanli Pharmaceutical Co.,Ltd$984M70BUY
300039.SZShanghai Kaibao Pharmaceutical CO.,Ltd$822M68BUY
002437.SZHARBIN GLORIA PHARMACEUTICALS Co., LTD$975M73BUY
688566.SSJiangsu Jibeier Pharmaceutical Co., Ltd.$741M65BUY
000597.SZNortheast Pharmaceutical Group Co., Ltd.$983M64HOLD
600195.SSChina Animal Husbandry Industry Co., Ltd.$996M64HOLD
603207.SSShanghai Xiao Fang Pharmaceutical Co.,Ltd.$556M70BUY
600557.SSJiangsu Kanion Pharmaceutical Co.,Ltd.$1.1B65HOLD
002550.SZChangzhou Qianhong Biopharma CO.,LTD$1.2B66BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) — Stock Score Summary

Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) has a MoatMap StockRank of 70/100 based on Quality (71/100), Value (58/100), and Momentum (28/100) factor scores. The current signal is BUY. Hunan Jiudian is a high-quality pharmaceutical company specializing in transdermal patches, but it does not operate as a global CDMO and lacks direct alignment with our macro themes.

Hunan Jiudian Pharmaceutical Co., Ltd. develops and manufactures pharmaceutical formulations, active ingredients (APIs), and excipients, with a market-leading specialization in transdermal drug delivery systems like gel patches. The company's competitive moat is its vertically integrated "API + formulation" business model and proprietary formulation technologies that yield high-barrier topical preparations. It is a fast-growing specialty pharmaceutical leader in China's pain management and transdermal patch markets.

Key Financial Metrics

Price$1.51
Market Cap$869M
P/E (TTM)12.91
P/E (Forward)7.42
Price/Book1.92
Return on Equity14.5%
Return on Invested Capital15.1%
Debt/Equity24.38
Gross Margin71.3%
Operating Margin11.7%
Revenue Growth-14.5%
Dividend Yield3.8%
Free Cash Flow$-5M

Hunan Jiudian Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Hunan Jiudian Pharmaceutical Co., Ltd.’s (300705.SZ) StockRank?
MoatMap’s StockRank for Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) is 70/100, with a Buy signal. It is a composite of Quality (71), Value (58), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Hunan Jiudian Pharmaceutical Co., Ltd. have an economic moat?
Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Hunan Jiudian Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) is Buy, based on a StockRank of 70/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Hunan Jiudian Pharmaceutical Co., Ltd. in?
Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).